Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market has witnessed rapid expansion in recent years. This market is expected to grow from $1.34 billion in 2025 to $1.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.6%. The historical surge in growth can be attributed to several factors, including progress in long-read sequencing technologies, a rise in research focused on transcriptome analysis, increased financial support for genomics research, the expanding adoption of PacBio and Nanopore platforms, and the broadening uses in gene expression studies.
The long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market is projected to experience substantial expansion in the coming years. This market is predicted to reach $3.18 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 18.9%. Factors contributing to this growth include the increasing need for precision medicine applications, greater integration of AI-driven bioinformatics tools, expanded application in rare disease research, the broadening scope of clinical transcriptomics, and the creation of more cost-effective long-read sequencing workflows. Key trends anticipated during this period encompass the increased uptake of single-cell full-length cDNA sequencing, a heightened demand for high-fidelity long-read platforms, its expanding utility in alternative splicing detection, the proliferation of transcript isoform characterization studies, and the increasing incorporation of sophisticated library preparation kits.
Get A Free Sample Report With In-Depth Market Insights:
Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Growth Factors Behind Sustained Expansion
An increasing emphasis on precision medicine is anticipated to fuel expansion within the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market in the foreseeable future. This medical strategy involves tailoring prevention methods and treatments based on a person’s unique genetic and molecular profiles. The heightened attention on precision medicine stems from an escalating demand for efficacious treatments for conditions that are diverse and do not respond well to conventional therapies. Long-read full-length cDNA sequencing improves clinical judgments by offering extensive understanding of transcript variants and relevant biomarkers, facilitating the more accurate choice of specific treatments. As an illustration, data from February 2024, provided by the US non-profit Personalized Medicine Coalition, showed that in 2023, the U.S. Food and Drug Administration (FDA) authorized 16 novel personalized treatments for individuals with rare illnesses, which signifies a considerable increase from the six approvals noted in 2022. Consequently, the expanding emphasis on precision medicine is a key impetus behind the advancement of the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market.
Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Segmentation: How Does The Market Break Down By Category?
The long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market covered in this report is segmented –
1) By Technology: Pacific Biosciences Single-Molecule Real-Time (PacBio SMRT), Oxford Nanopore, Other Technologies
2) By Product Type: Instruments And Sequencing Platforms, Reagents And Consumables, Library Preparation Kits, Flow Cells And Chips, Data Analysis Software And Bioinformatics Tools
3) By Sample Type: Human, Animal, Plant, Microbial
4) By Application: Transcriptome Analysis, Gene Expression Studies, Alternative Splicing Detection, Fusion Gene Detection, Other Application
5) By End-Users: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End Users
Subsegments:
1) By Pacific Biosciences Single-Molecule Real-Time (PacBio SMRT): Sequel System, Sequel II System, RS II System, High-Fidelity Sequencing Systems
2) By Oxford Nanopore: MinION Sequencing Devices, GridION Sequencing Platforms, PromethION Sequencing Platforms, Flongle Sequencing Modules
3) By Other Technologies: Synthetic Long-Read Sequencing, Linked-Read Sequencing, Single-Cell Full-Length cDNA Sequencing, Hybrid Sequencing Approaches
Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Industry Trends Fueling Future Revenue Growth
Major companies engaged in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market are concentrating on developing innovative solutions, such as high-fidelity single-molecule sequencing platforms, to enhance transcript accuracy and detect complex RNA isoforms. These high-fidelity single-molecule sequencing platforms facilitate the accurate capture of full-length transcripts and the detection of complex RNA isoforms in one run, by reading entire cDNA molecules with low error rates and without fragmentation. For instance, in December 2023, Pacific Biosciences of California Inc., a US-based biotechnology company, launched Kinnex RNA kits specifically designed to advance RNA research. This technology integrates high-fidelity single-molecule sequencing platforms with optimized library preparation workflows to generate highly accurate, long-read transcriptome data. Its defining features include ultra-long reads spanning whole transcripts, high consensus accuracy, and adaptability to complex RNA samples, enabling researchers to identify alternative splicing, fusion transcripts, and novel isoforms with unparalleled precision. Kinex finds utility in genomics, transcriptomics, biomarker discovery, and therapeutic target identification, offering a more comprehensive understanding of RNA biology than conventional methodologies.
Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market are Eurofins Scientific SE, Bio-Rad Laboratories Inc., QIAGEN N.V., 10x Genomics Inc., Azenta Life Sciences Inc., BGI Genomics Co. Ltd., Novogene Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., New England Biolabs Inc., Macrogen Inc., DNAnexus Inc., Zymo Research Corporation, CD Genomics Inc., BaseClear B.V., Microsynth AG, Creative Biogene Inc., Nucleome Informatics Inc., Operify Tech Pvt. Ltd., Signios Bio Inc.
View The Full Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Report:
Long-Read Full-Length Complementary Deoxyribonucleic Acid (cDNA) Sequencing Market Geographic Spread And Regional Opportunities
North America was the largest region in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read full-length complementary deoxyribonucleic acid (cDNA) sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
